The non‑cystic fibrosis bronchiectasis treatment market is growing due to increased diagnosis, expanded use of macrolide antibiotics, inhaled mucolytics, and airway clearance devices in respiratory care. https://www.datamintelligence.com/research-report/non-cystic-fibrosis-bronchiectasis-treatment-market